Vertex, CRISPR and Bluebird Bio Receive FDA Approval for Two Gene Therapies for Sickle Cell
For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene [...]